(631) 444-3577
- Specialty:
Subspecialty:
- Internal Medicine
Hematology/Oncology, Hematologic Malignancies, Hematopoietic Stem Cell Transplantation
- Administrative/ Clinical Title:
- Director, Hematopoietic Stem Cell Transplantation Program
Director, Hematologic Malignancy Program
MICHAEL SCHUSTER MD
For Appointments:
(631) 444-3577
ALLOGENEIC TRANSPLANTS
APLASTIC ANEMIA
AUTOLOGOUS TRANSPLANTS
BENIGN HEMATOLOGICAL DISORDERS
BLEEDING DISORDERS
BONE MARROW TRANSPLANT
BREAST CANCER
CHRONIC MYELOGENOUS LEUKEMIA (CML)
HAPLOIDENTICAL TRANSPLANT
HEMATOLOGIC MALIGNANCY
HODGKIN'S DISEASE
LEUKEMIA
LYMPHOMA
MATCHED UNRELATED DONOR (MUD) ALLOGENEIC TRANSPLANT
MATCHED UNRELATED TRANSPLANTS
MISMATCHED TRANSPLANTS
MULTIPLE MYELOMA
MYELODYSPLASTIC SYNDROME
MYELOPROLIFERATIVE DISEASE
UMBILICAL CORD BLOOD TRANSPLANTS
1199NBF
AETNA
AFFINITY HEALTH PLAN
BEECH STREET
CIGNA GREAT WEST HEALTHCARE
CIGNA HMO
CIGNA PPO
EMPIRE BLUE CROSS HMO
EMPIRE BLUE CROSS OTHER PLANS
EMPIRE BLUE CROSS PPO
EMPIRE BLUE CROSS SENIOR PLAN
FIDELIS CARE NEW YORK
GHI CBP
GHI HMO
HEALTHFIRST
HIP
ISLAND GROUP ADMINISTRATION
MAGNACARE
MEDICAID
MEDICARE
MULTIPLAN
MULTIPLAN PHCS
MULTIPLAN SAVILITY
NEIGHBORHOOD HEALTH PLAN
NO FAULT
SUFFOLK HEALTH PLAN
UNITED EMPIRE PLAN (NYSHIP)
UNITED HEALTHCARE
UNITED OXFORD FREEDOM PLAN
VYTRA (except SMART START)
WORKERS COMP
Education & Training
- Medical Degree:
- Dartmouth Medical School, NH
- Residency:
- Internal Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, MA
- Fellowship:
-
Hematology/Oncology, Beth Israel Deaconess Medical Center/Harvard Medical School, MA
Academic & Other
- Teaching Activity:
- Internal Medicine
- Year Appointed at
Stony Brook:
- 2010
America's Top Doctors, Castle Connolly, LTD, 8 consecutive years, 2001 - 2008
New York Magazine's Best Doctors in New York, 9 consecutive years, 2002 - 2010
America's Top Doctors For Cancer, Castle Connolly, LTD, 5 consecutive years, 2005 - 2009
Top Doctors: NY Metro Area, Castle Connolly, LTD, 7 consecutive years, 6th edition - 12th edition
Member of:
American Medical Association
American College of Physicians
American Society of Clinical Oncology
American Society of Hematology
New York Blood Club
American Society of Bone Marrow and Stem Cell Transplantation
International Society for Hematotherapy and Graft Engineering
The Bone Marrow Foundation (Board of Advisors Member)
Research
Cytokines
Transplantation immunology
New drug development in hematological malignancies and cancer
Detection of minimal residual disease in lymphoma
MDR expression in leukemic cells
Cachexia
- Clinical Practice Began:
- 1987
Locations
-
INTERNAL MEDICINE
3 EDMUND D PELLEGRINO RD,
STONY BROOK,
NY 11794-9447.
Ph.: 631-638-1000
-
INTERNAL MEDICINE
3003 NEW HYDE PARK ROAD,
NEW HYDE PARK,
NY 10042-1206.
Ph.: 631-278-6015
Fax: 516-488-8048
-
INTERNAL MEDICINE
331 EAST 65TH STREET,
STE 1,
NEW YORK,
NY 10065-6881.
Ph.: 631-278-6015
Fax: 212-439-1684
Selected Publications
1. Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T,Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, San-Miguel JF, Blade J, Boccadoro M, Cavenagh J, Dalton WS, Boral AL, Esseltine DL, Porter JB, Schenkein D, Anderson KC. Bortezomib or high- dose dexamethasone for relapsedmultiple myeloma. N Engl J Med. 2005 Jun 16;352(24):2546-8.
2. Shore T, Harpel J, Schuster MW, Roboz GJ, Leonard JP, Coleman M, Feldman EJ, Silver RT. A study of a reduced-intensity conditioning regimen followed by allogeneic Stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy. Biol Blood Marrow Transplant. 2006 Aug;12(8):868-75.
3. Lee SJ, Richardson PG, Sonneveld P, Schuster MW, Irwin D, San Miguel JF, Crawford B, Massaro J, Dhawan R, Gupta S, Anderson KC. Bortezomib is associated with better Health- related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study. Br J Haematol. 2008 Nov;143(4):511-9.
4. William J. Evans, John E. Morley, Josep Argiles, Connie Bales, Vickie Baracos, Denis Guttridge, Aminah Jatoi, Kamyar Kalantar-Zadeh, Herbert Lochs, Giovanni Mantovani, Daniel Marks, William E. Mitch, Maurizio Muscaritoli, Armine Najand, Piotr Ponikowski, Filippo Rossi Fanelli, Morrie Schambelan, Annemie Schols, Michael Schuster, David Thomas, Robert Wolfe, Stefan Anker, Cachexia: A New Definition. Clinical Nutrition Volume 27, Issue 6, December 2008, Pages 793-799.
5. Richardson PG, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, Blad J, Boccadoro M, Cavenagh JD, Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline. Br J Hematol. 2009 Mar;144(6):895-903. Epub 2009 Jan 16.
6. SS Yeh, S. Lovitt, MW Schuster, Usage of Megesterol Acetate in the Treatment of Anorexia-Cachexia Syndrome in the Elderly. The Journal of Nutrition, Health and Aging, 2009 May; 13(5):448-54.
7. Sergio A. Giralt, William I. Bensinger, and Michael W. Schuster, The Hematology Circle: Optimizing Pretransplant Induction Regimens for Multiple Myeloma and Myelodysplastic Syndromes. Blood and Marrow Transplantation Reviews: Volume 19, Issue 1, 2009.
8. Paul J. Martin, Carlos R. Bachier, Hans-Georg Klingemann, Philip L. McCarthy, Paul Szabolcs, Joseph P. Uberti, Michael W. Schuster, Daniel Weisdorf, Nelson J. Chao,
Partow Kebriaei, Elizabeth J. Shpall, Margaret L.MacMillan, Robert J. Soiffer, Endpoints for Clinical Trials Testing Treatment of Acute Graft-versus-Host Disease: A Joint Statement, Biol Blood Marrow Transplant. 2009 Jul;15(7):777-84. Epub 2009 May 13.
9. Partow Kebriaei, Luis Isola, Erkut Bahceci, Kwent Holland, Scott Rowley, Joseph
McGirk, Marcel Devetten, Jan Jansen, Roger Herzig, Michael Schuster, Rod Monroy and Joseph Uberti, Adult Human Mesenchymal Stem Cells Added to Corticosteroid
Therapy Improves Outcomes of Graft Versus Host Disease, Biology of Blood and Marrow Transplantation. 2009 Jul;15(7):804-11
Personal Statement
There are 700 + physicians and other health care providers practicing within 18 different clinical entities, or specialty groups that are affiliated with Stony Brook University Physicians (SBU Physicians). Together, these providers offer patients of all ages a comprehensive range of high quality medical services, from primary care to advanced specialty care. The physicians and health care professionals affiliated with SBU Physicians are committed to excellence in service and leadership in clinical care. In their capacity as faculty of the Stony Brook University School of Medicine, they also educate medical students, interns, residents and fellows in many specialties and sub-specialties, and engage in research and clinical trials that help to advance the science of medicine.
These physicians and health care professionals are committed to excellence in service and leadership in clinical care for their patients. SBU Physicians supports and coordinates this mission and maintains this website for patients, physicians and staff.
